Delivery Order SPE2DB22D2206-SPE2DB23FKM89

Award Date 9/25/23
Potential Completion Date 9/26/23
Potential Value $106K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS to the Defense Logistics Agency (DLA), a defense agency. The $5,370.54 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024, with a completion date of October 29, 2024. This order is a part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $2,111.16. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 30, 2024. The contract does not have a set-aside designation. This award is likely part of a larger Indefinite...
This federal contract award is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $13,258.87. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 25, 2024. The contract does not have a set-aside designation,...
This federal contract award, valued at $76,959.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS to the Defense Logistics Agency (DLA). The contract, valued at $18,296.72, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a completion date of February 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,364.24, is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty medication. The contract has a firm fixed price and an ultimate completion date of November 21, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award is for the procurement of LUPRON DEPOT 22.5 MG 3MO KITS, a specialty pharmaceutical product, by the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,828.85 with a firm fixed price and an ultimate completion date of February 18, 2025. This award is not associated with a set-aside designation, indicating open...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LUPRON DEPOT 22.5 MG 3MO KITS. The contract, valued at $5,262.56, has a completion date of November 22, 2024 and was awarded on November 21, 2024. The contract is a Delivery Order under a Firm Fixed Price contract type. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen holds a larger...
This federal contract award is for the delivery of LUPRON DEPOT 22.5 MG 3MO KITS to the Defense Logistics Agency (DLA). The contract, valued at $3,522.45, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 16, 2024. The contract has an ultimate completion date of August 19, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous federal...
This federal contract award, valued at $20,767.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for LUPRON DEPOT 11.25 MG 3MO KITS, a medication used in various medical treatments. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB23FKM89
    Delivery Order

This federal contract award is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $106,281.91, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 9:57 AM